[Free Webinar] Midbrain Organoids for Parkinson's Drug Development

[Free Webinar] Midbrain Organoids for Parkinson's Drug Development

Collaboration offers

Information

Derived from healthy or patient human cells, midbrain organoids make a 3D drug screening platform for Parkinson’s disease, providing results that cannot readily be replicated in 2D cultures. On October 15th, at 16:00, we will explore the use of organoids at the webinar presented in collaboration with our partner OrganoTherapeutics. Learn more and register for free at https://www.innoserlaboratories.com/mbo-webinar-2020/
URL
https://www.innoserlaboratories.com/mbo-webinar-2020/
InnoSerFounded in 2012, InnoSer is an innovative and dynamic contract research organization (CRO) supporting discovery and preclinical development of drugs. InnoSer’s offerings include PDXO screening platform for oncology, ADPKD mouse model for nephrology, and validated midbrain organoid model for Parkinson’s disease. It also provides pathology, in-vivo imaging and genetically engineered mice model services like colony management, cryopreservation, sanitation/rederivation. Visit our kfg page to learn more www.innoserlaboratories.com/kfg2020

Join the event!